{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:30:59Z","timestamp":1786545059395,"version":"build-2736575974"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/ajg.2010.409","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T13:26:11Z","timestamp":1299245171000},"page":"386-392","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of GERD and Proton Pump Inhibitor Use in the Elderly: Practical Approaches and Frequently Asked Questions"],"prefix":"10.14309","volume":"106","author":[{"given":"Shannon","family":"Scholl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365529309096078","article-title":"Features of symptomatic gastroesophageal reflux in elderly patients.","volume":"28","author":"Zhu","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"R2-2-20210210","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1440-1746.2002.02783.x","article-title":"Clinical characteristics and natural history of patients with low-grade reflux esophagitis.","volume":"17","author":"Manabe","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R3-2-20210210","first-page":"1053","article-title":"Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy.","volume":"90","author":"Collen","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"R4-2-20210210","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2003.12.001","article-title":"Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease.","volume":"126","author":"Johnson","year":"2004","journal-title":"Gastroenterology"},{"key":"R5-2-20210210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ageing\/20.5.365","article-title":"Symptoms of gastro-oesophageal reflux disease in elderly people.","volume":"20","author":"Raiha","year":"1991","journal-title":"Age Ageing"},{"key":"R6-2-20210210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/ajg.2009.250","article-title":"Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults.","volume":"104","author":"Horiuchi","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R7-2-20210210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.gie.2006.02.001","article-title":"ASGE guideline: modifications in endoscopic practice for the elderly.","volume":"63","author":"Qureshi","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"R8-2-20210210","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barretts esophagus.","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R9-2-20210210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.2007.03579.x","article-title":"Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barretts oesophagus.","volume":"27","author":"Hillman","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-2-20210210","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cgh.2009.06.001","article-title":"Medication usage and the risk of neoplasia in patients with Barretts esophagus.","volume":"7","author":"Nguyen","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-2-20210210","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/ajg.2009.504","article-title":"Quality of life in GERD and Barretts esophagus is related to gender and manifestation of disease.","volume":"104","author":"Lippmann","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R12-2-20210210","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0002-9270(03)00010-8","article-title":"The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease.","volume":"98","author":"Ofman","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R13-2-20210210","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1365-2036.2006.03127.x","article-title":"Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.","volume":"24","author":"Jalving","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R14-2-20210210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.1040876","article-title":"Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.","volume":"171","author":"Dial","year":"2004","journal-title":"CMAJ"},{"key":"R15-2-20210210","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"R16-2-20210210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0889-8553(05)70202-8","article-title":"Infectious diarrhea in the elderly.","volume":"30","author":"Slotwiner-Nie","year":"2001","journal-title":"Gastroenterol Clin North Am"},{"key":"R17-2-20210210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003088-199223060-00006","article-title":"Pharmacokinetic study of omeprazole in elderly healthy volunteers.","volume":"23","author":"Landahl","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"R18-2-20210210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2125.1993.tb00398.x","article-title":"Single and multiple dose pharmacokinetics of lansoprazole in elderly subjects.","volume":"36","author":"Flouvat","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"R19-2-20210210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003088-200140020-00006","article-title":"Pharmacokinetic study of esomeprazole in the elderly.","volume":"40","author":"Hasselgren","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R20-2-20210210","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.2165\/00003495-200363240-00004","article-title":"Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.","volume":"63","author":"Robinson","year":"2003","journal-title":"Drugs"},{"key":"R21-2-20210210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","article-title":"Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.","volume":"143","author":"Hampel","year":"2005","journal-title":"Ann Intern Med"},{"key":"R22-2-20210210","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMoa054391","article-title":"Body-mass index and symptoms of gastroesophageal reflux in women.","volume":"354","author":"Jacobson","year":"2006","journal-title":"N Engl J Med"},{"key":"R23-2-20210210","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"R24-2-20210210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R25-2-20210210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events.","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"R26-2-20210210","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2009.05.050","article-title":"Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose: the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.","volume":"54","author":"Cuisset","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R27-2-20210210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FJC.0b013e3181e19739","article-title":"Pantoprazole does not influence the antiplatelet effect of clopidogrel: a whole blood aggregometry study after coronary stenting.","volume":"56","author":"Neubauer","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"R28-2-20210210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.","volume":"180","author":"Juurlink","year":"2009","journal-title":"CMAJ"},{"key":"R29-2-20210210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinternmed.2010.34","article-title":"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.","volume":"170","author":"Stockl","year":"2010","journal-title":"Arch Intern Med"},{"key":"R32-2-20210210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.2003.01550.x","article-title":"A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.","volume":"17","author":"Labenz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-2-20210210","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2008.08.044","article-title":"American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"R34-2-20210210","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/BF01296606","article-title":"Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.","volume":"36","author":"Humphries","year":"1991","journal-title":"Dig Dis Sci"},{"key":"R35-2-20210210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00007691-198903000-00010","article-title":"Stereoselective interaction of omeprazole with warfarin in healthy men.","volume":"11","author":"Sutfin","year":"1989","journal-title":"Ther Drug Monit"},{"key":"R36-2-20210210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003088-199631010-00002","article-title":"Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.","volume":"31","author":"Andersson","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R37-2-20210210","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2036.2007.03458.x","article-title":"Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin.","volume":"26","author":"Taha","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R38-2-20210210","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Wetterhus S et al.. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"R39-2-20210210","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cgh.2006.08.018","article-title":"Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993-2003.","volume":"4","author":"Targownik","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R40-2-20210210","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","article-title":"Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.","volume":"160","author":"Agrawal","year":"2000","journal-title":"Arch Intern Med"},{"key":"R41-2-20210210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002512-200825030-00003","article-title":"Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients.","volume":"25","author":"Blandizzi","year":"2008","journal-title":"Drugs Aging"},{"key":"R42-2-20210210","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","article-title":"Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.","volume":"103","author":"Yeomans","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R43-2-20210210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0016-5107(02)70402-1","article-title":"Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures.","volume":"55","author":"Eisen","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"R44-2-20210210","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"R45-2-20210210","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"R46-2-20210210","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2009.09.012","article-title":"Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.","volume":"54","author":"Becker","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R47-2-20210210","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"R48-2-20210210","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents.","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"R49-2-20210210","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/01.CIR.103.15.1967","article-title":"Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.","volume":"103","author":"Cutlip","year":"2001","journal-title":"Circulation"},{"key":"R50-2-20210210","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"R51-2-20210210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.108.804203","article-title":"Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.","volume":"119","author":"Aoki","year":"2009","journal-title":"Circulation"},{"key":"R52-2-20210210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2007.04.059","article-title":"Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.","volume":"50","author":"Sianos","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R53-2-20210210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","article-title":"Endoscopic sphincterotomy complications and their management: an attempt at consensus.","volume":"37","author":"Cotton","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"R54-2-20210210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy.","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"key":"R55-2-20210210","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0016-5107(94)70210-1","article-title":"Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS.","volume":"40","author":"Shiffman","year":"1994","journal-title":"Gastrointest Endosc"},{"key":"R56-2-20210210","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.CIR.0000145171.89690.B4","article-title":"Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes.","volume":"110","author":"Collet","year":"2004","journal-title":"Circulation"},{"key":"R57-2-20210210","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/bja\/ael083","article-title":"Coronary artery stenting and non-cardiac surgery: a prospective outcome study.","volume":"96","author":"Vicenzi","year":"2006","journal-title":"Br J Anaesth"},{"key":"R58-2-20210210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004836-198702000-00006","article-title":"Esophageal acid sensitivity in Barretts esophagus.","volume":"9","author":"Johnson","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"R59-2-20210210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","article-title":"Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.","volume":"138","author":"Inadomi","year":"2003","journal-title":"Ann Intern Med"},{"key":"R60-2-20210210","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/archinte.1991.00400110070014","article-title":"Barretts esophagus. Prevalence and incidence of adenocarcinoma.","volume":"151","author":"Williamson","year":"1991","journal-title":"Arch Intern Med"},{"key":"R61-2-20210210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(84)90090-8","article-title":"Adenocarcinoma and Barretts esophagus. An overrated risk?","volume":"87","author":"Spechler","year":"1984","journal-title":"Gastroenterology"},{"key":"R62-2-20210210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0889-8553(05)70308-3","article-title":"Epidemiology of columnar-lined esophagus and adenocarcinoma.","volume":"26","author":"Cameron","year":"1997","journal-title":"Gastroenterol Clin North Am"},{"key":"R63-2-20210210","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1572-0241.1999.01276.x","article-title":"Barretts esophagus: a new look at surveillance based on emerging estimates of cancer risk.","volume":"94","author":"Provenzale","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R64-2-20210210","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2005.03.077","article-title":"American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma.","volume":"128","author":"Wang","year":"2005","journal-title":"Gastroenterology"},{"key":"R65-2-20210210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.gie.2005.06.047","article-title":"Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barretts esophagus: international, partially blinded, randomized phase III trial.","volume":"62","author":"Overholt","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"R66-2-20210210","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","article-title":"Radiofrequency ablation in Barretts esophagus with dysplasia.","volume":"360","author":"Shaheen","year":"2009","journal-title":"N Engl J Med"},{"key":"R67-2-20210210","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00004836-199206000-00005","article-title":"Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy.","volume":"14","author":"Koop","year":"1992","journal-title":"J Clin Gastroenterol"},{"key":"R68-2-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-120-3-199402010-00006","article-title":"Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12).","volume":"120","author":"Marcuard","year":"1994","journal-title":"Ann Intern Med"},{"key":"R69-2-20210210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2036.1996.27169000.x","article-title":"Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin.","volume":"10","author":"Schenk","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"R70-2-20210210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2036.1992.tb00553.x","article-title":"Review article: Metabolic consequences of long-term inhibition of acid secretion by omeprazole.","volume":"6","author":"Koop","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"R71-2-20210210","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture.","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"R72-2-20210210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","article-title":"Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.","volume":"79","author":"Vestergaard","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"R73-2-20210210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures.","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ"},{"key":"R74-2-20210210","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1592\/phco.28.8.951","article-title":"Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.","volume":"28","author":"Kaye","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R75-2-20210210","first-page":"1376","article-title":"Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects.","volume":"10","author":"Graziani","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"R76-2-20210210","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.","volume":"138","author":"Targownik","year":"2010","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2010409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010409","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201103000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:35:36Z","timestamp":1786541736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201103000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.409","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}